CBD Oil Education

Psycholog w krainie konopi. Wypróbowałam na sobie olejki CBD!



KOD ZNIŻKOWY NA PIERWSZE ZAMÓWIENIE: PSYCHOLOGPISZE
https://bit.ly/31pj41i
~~~
*Źródła:

Russo M, Calabrò RS, Naro A, Sessa E, Rifici C, D’Aleo G, Leo A, De Luca R, Quartarone A, Bramanti P. Sativex in the management of numerous sclerosis-related spasticity: part of the corticospinal modulation. Neural Plast. 2015;2015:656582.

Genaro K, Fabris D, Arantes ALF, Zuardi AW, Crippa JAS, Prado WA. Cannabidiol Is a Possible Therapeutic for its Affective-Motivational Dimension of Incision Pain in Rats. Front Pharmacol. 2017;8:391. Released 2017 Jun 21.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: A Evidence Inspection and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Present Condition of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); 2017 Jan 12. Two, Cannabis.

Hill KP, Palastro MD, Johnson B, Ditre JW. Cannabis and Anxiety: A Clinical Overview. Cannabis Cannabinoid Res. 2017;two (1):96-104. Released 2017 May 1.

Shannon S, Opila-Lehman J. Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report. Perm J. 2016;20(4):16-005.

Iseger TA, Bossong MG. A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophr Res. 2015 Mar;162(1-3):153-61.

Prud’homme M, Cata R, Jutras-Aswad D. Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence. Subst Abuse. 2015;9:33-38. Published 2015 May 21.

McAllister SD, Soroceanu L, Desprez PY. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids. J Neuroimmune Pharmacol. 2015 Jun;10(2):255-67.

Weiss L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavin S, Gallily R. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity. 2006 Mar;39(2):143-51.

Kerstin Iffland and Franjo Grotenhermen. ) Cannabis and Cannabinoid Research.Dec 2017.139-154.

Flachenecker P, Henze T, Zettl UK. Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice–results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity. Eur Neurol. 2014;71(5-6):271-9.

Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, Miller I, Flamini R, Wilfong A, Filloux F, Wong M, Tilton N, Bruno P, Bluvstein J, Hedlund J, Kamens R, Maclean J, Nangia S, Singhal NS, Wilson CA, Patel A, Cilio MR. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016 Mar;15(3):270-8.

Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S; Cannabidiol in Dravet Syndrome Study Group. Trial of Cannabidiol to Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017 May 25;376(21):2011-2020.

Chagas MH, Eckeli AL, Zuardi AW, Pena-Pereira MA, Sobreira-Neto MA, Sobreira ET, Camilo MR, Bergamaschi MM, Schenck CH, Hallak JE, Tumas V, Crippa JA. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series. J Clin Pharm Ther. 2014 Oct;39(5):564-6.

Chagas MH, Zuardi AW, Tumas V, Pena-Pereira MA, Sobreira ET, Bergamaschi MM, dos Santos AC, Teixeira AL, Hallak JE, Crippa JA. Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial. J Psychopharmacol. 2014 Nov;28(11):1088-98.

Watt G, Karl T. In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s Disease. Front Pharmacol. 2017;8:20. Published 2017 Feb 3.

Cheng D, Spiro AS, Jenner AM, Garner B, Karl T. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice. J Alzheimers Dis. 2014;42(4 ) ):1383-96.

Iseger TA, Bossong MG. A systematic overview of these properties of cannabidiol in people. Schizophr Res. 2015 Mar;162(1-3):153-61.

Prud’homme M, Cata R, Jutras-Aswad D. Cannabidiol within an Intervention for Addictive Behaviors: An Extensive Review of the Evidence. Subst Abuse. 2015;9:33-38. Released 2015 May 21.

McAllister SD, Soroceanu L, Desprez PY. The Antitumor Action of Plant-Derived Non-Psychoactive Cannabinoids. J Neuroimmune Pharmacol. 2015 Jun;10(two ):255-67.

Welty TE, Luebke A, Gidal BE. Cannabidiol: promise along with pitfalls. Epilepsy Curr. 2014;14(5):250-252.

https://www. ) mdpi.com/454532

origin

Related Articles

Close
Close